🟢 Cue Biopharma is trading 6% up today as flat July PPI eased rate-hike concerns

Cue Biopharma is trading 5.95% up at $32.23, likely supported by broader risk-on sentiment after flat July PPI eased rate-hike concerns.

• No verified company-specific announcement was identified for August 13, 2026.
• The latest official release remains the August 3 CFO appointment and CUE-221 IND submission, which does not directly explain today’s move.
• Major indexes advanced, including the Nasdaq Composite, up 1.03%.